Tecan Group AG Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
TECN Community Narratives
TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value
Lab Automation And Personalized Medicine Will Unlock Secular Opportunities
Tariffs And Disruptions Will Crush Margins While Cuts Will Help
TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value
View narrativeTariffs And Disruptions Will Crush Margins While Cuts Will Help
View narrativeLab Automation And Personalized Medicine Will Unlock Secular Opportunities
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
TECN: Margin Execution And 2028 Goals Will Shape Fairly Valued Outlook
TECN: Margin Execution Concerns Will Constrain Upside Despite Raised Expectations
TECN: Margin Upside And India Expansion Will Support Future Earnings Re Rating
Snowflake Analysis
Tecan Group AG Key Details
- -9.44
- 34.06%
- -13.36%
- 13.6%
About TECN
- Founded
- 1980
- Employees
- 3000
- CEO
- Website
View website
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.